Literature DB >> 16751133

Serum levels of Thl/Th2 cytokines, angiogenic growth factors, and other prognostic factors in young adult patients with hemophagocytic syndrome.

Ikuo Murohashi1, Katsuhiko Yoshida, Noriko Ihara, Daisuke Wakao, Fumiharu Yagasaki, Yuichi Nakamura, Nobutaka Kawai, Akira Matsuda, Itsuro Jinnai, Masami Bessho.   

Abstract

Serum levels of T helper 1 (Th1)/T helper 2 (Th2) cytokines, angiogenic growth factors, and other prognostic factors were measured in 5 young adult patients with virus-associated hemophagocytic syndrome (HPS). Levels of 2 Th1 cytokines (interleukin [IL]-18 and tumor necrosis factor-alpha), 2 Th2 cytokines (IL-10 and IL-6), and 2 angiogenic growth factors (soluble intercellular adhesion molecule-1 and hepatocyte growth factor) were high in all of the patients examined, whereas those of Th1 cytokines such as IL-12 and macrophage inflammatory protein-1a were normal or low. Levels of IL-18 and IL-10 were highest in case 2, with a fatal outcome, and were lowest in case 4, with rapid recovery within 1 month. Although IFN-gamma levels were not elevated in 2 patients (cases 3 and 5), IL-18 levels were markedly high in both of these cases and the IL-6 level was highest in case 3. In contrast with the marked increase in the level of IL-10, the levels of IL-6, sIL-2R, and ferritin decreased rapidly and returned to normal within 2 months after therapy in case 3. The IL-18 level decreased somewhat, but remained elevated for 6 months, and the patient achieved a complete response within 11 months. Taken together, our findings suggest that both IL-18 and IL-10, but not IL-12, may play important roles in young adult patients with HPS via enhancing and suppressing Th1 immune responses, respectively.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16751133     DOI: 10.1532/LH96.05035

Source DB:  PubMed          Journal:  Lab Hematol        ISSN: 1080-2924


  4 in total

1.  Gene expression profiling of peripheral blood mononuclear cells from children with active hemophagocytic lymphohistiocytosis.

Authors:  Janos Sumegi; Michael G Barnes; Shawnagay V Nestheide; Susan Molleran-Lee; Joyce Villanueva; Kejian Zhang; Kimberly A Risma; Alexei A Grom; Alexandra H Filipovich
Journal:  Blood       Date:  2011-02-16       Impact factor: 22.113

2.  Hemophagocytic lymphohistiocytosis: epidemiological, clinical and biological profile

Authors:  Hanane Zahir; Jihane Belkhir; Hanane Mouhib; Mustapha Ait Ameur; Mohammed Chakour
Journal:  Turk J Med Sci       Date:  2019-10-24       Impact factor: 0.973

3.  Acute hepatitis A infection-associated hemophagocytic lymphohistiocytosis in adult presenting as impending acute liver failure: A case report and literature review.

Authors:  Panotpol Termsinsuk; Piyaporn Sirisanthiti
Journal:  Clin Case Rep       Date:  2022-02-07

4.  IP-10/CXCL10 and MIG/CXCL9 as novel markers for the diagnosis of lymphoma-associated hemophagocytic syndrome.

Authors:  Hayato Maruoka; Daichi Inoue; Yoko Takiuchi; Seiji Nagano; Hiroshi Arima; Sumie Tabata; Akiko Matsushita; Takayuki Ishikawa; Tatsuo Oita; Takayuki Takahashi
Journal:  Ann Hematol       Date:  2013-08-25       Impact factor: 3.673

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.